BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 12883240)

  • 1. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
    Tambouret R; Clement PB; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J; McCluggage WG
    Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma.
    Mai KT; Perkins DG; Yazdi HM; Thomas J
    Hum Pathol; 2002 Aug; 33(8):856-8. PubMed ID: 12203221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Deceptive Spread: Myoinvasion of Endometrial Carcinoma Imitating Adenoma Malignum.
    Deb PQ; Marcus JZ; Abedin Y; Heller DS
    Int J Surg Pathol; 2020 May; 28(3):284-286. PubMed ID: 31690149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grossly unremarkable cervix in endometrial carcinomas: lymphovascular space invasion and microcystic elongated and fragmented pattern may be associated with high incidence of cervical stromal involvement.
    Zhang Y; Jeyachandran D; Desouki MM
    Hum Pathol; 2021 Jul; 113():59-66. PubMed ID: 33933559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
    Quick CM; May T; Horowitz NS; Nucci MR
    Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study.
    McCluggage WG; Hirschowitz L; Wilson GE; Oliva E; Soslow RA; Zaino RJ
    Am J Surg Pathol; 2011 Feb; 35(2):289-94. PubMed ID: 21263250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertoliform endometrial adenocarcinoma: a study of four cases.
    Eichhorn JH; Young RH; Clement PB
    Int J Gynecol Pathol; 1996 Apr; 15(2):119-26. PubMed ID: 8786200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of cervical glandular neoplasia and issues in differential diagnosis.
    Loureiro J; Oliva E
    Arch Pathol Lab Med; 2014 Apr; 138(4):453-83. PubMed ID: 24678677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.
    Young RH; Clement PB
    Histopathology; 2002 Sep; 41(3):185-207. PubMed ID: 12207781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis.
    Kalyanasundaram K; Ganesan R; Perunovic B; McCluggage WG
    Int J Surg Pathol; 2010 Apr; 18(2):138-43. PubMed ID: 19117974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
    Garuti G; De Giorgi O; Sambruni I; Cellani F; Luerti M
    Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
    McCluggage WG; Sumathi VP; McBride HA; Patterson A
    Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible.
    Zaino RJ; Abendroth C; Yemelyanova A; Oliva E; Lim D; Soslow R; DeLair D; Hagemann IS; Montone K; Zhu J
    Gynecol Oncol; 2013 Jan; 128(1):83-87. PubMed ID: 23063759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
    Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.